Dhavanika Chemicals: Pioneering Healthcare Advancements in Gujarat

Dhvanika Chemicals is gearing up for a significant expansion with plans to establish a new Active Pharmaceutical Ingredients (API) plant in Manjusar, Gujarat. The project has received approval for environmental clearance from the Gujarat State Environment Impact Assessment Authority (SEIAA) in March 2024, marking a crucial milestone for its implementation. With a budget of Rs. 8 crore, the plant is poised to enhance the region's pharmaceutical manufacturing capabilities.

Designed to have a monthly capacity of 1600 Tons, the API plant will produce a diverse range of active pharmaceutical ingredients, including intermediates for medicines, agrochemicals, and polymers. This comprehensive production line reflects Dhvanika Chemicals' commitment to catering to various industry needs and contributing to the healthcare and agricultural sectors.

The project is expected to create approximately 80 new employment opportunities, providing a significant boost to the local economy and job market in Manjusar, Gujarat. This job creation aspect underscores the project's potential to drive socio-economic development in the region.

Located at Plot No. 5415/P-1/P/2/A-4, GIDC Estate, Manjusar, Vadodara, Gujarat, the proposed API manufacturing unit represents a new venture for Dhvanika Chemicals in the industrial sector. With a projected annual capacity of 4800 MT, the project is categorized as a new industrial endeavor falling under Project Sector - Industrial Projects - 3 and Project Category - B2.

As Dhvanika Chemicals moves forward with its API plant project, it aims to not only expand its operations but also contribute to the growth and development of Gujarat's pharmaceutical industry. The project's approval and subsequent implementation highlight the company's dedication to innovation, sustainability, and meeting market demands.